Renalytix AI plc DSO Ratio 2011-2026 | RNLX

Annual DSO Ratio Renalytix AI plc

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
15.9	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
15.9	15.9	15.9

Quarterly DSO Ratio Renalytix AI plc

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
12.2	-	17.1	12.9	19.9	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
19.9	12.2	15.5

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
Bioventus BVS	82.1	$ 8.9	0.39 %	$ 593 M	USA
Castle Biosciences CSTL	49.2	$ 26.03	0.75 %	$ 723 M	USA
Aspira Women's Health AWH	50.7	-	-6.19 %	$ 10.5 M	USA
DexCom DXCM	87	$ 68.22	2.83 %	$ 26.6 B	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
Guardant Health GH	46.1	$ 87.75	0.66 %	$ 11 B	USA
Charles River Laboratories International CRL	65	$ 153.51	1.02 %	$ 7.61 B	USA
CareDx, Inc CDNA	51.5	$ 17.49	0.98 %	$ 932 M	USA
Accelerate Diagnostics AXDX	291	-	-61.36 %	$ 2.46 M	USA
Exact Sciences Corporation EXAS	30.8	$ 103.9	0.04 %	$ 19.6 B	USA
IQVIA Holdings IQV	73.9	$ 169.08	2.54 %	$ 29.1 B	USA
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
Fulgent Genetics FLGT	77.4	$ 15.52	3.81 %	$ 469 M	USA
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Biodesix BDSX	41.7	$ 16.45	-4.86 %	$ 2.13 B	USA
ICON Public Limited Company ICLR	68.5	$ 100.08	2.53 %	$ 8.25 B	Irlanda
Anixa Biosciences ANIX	275	$ 2.86	0.83 %	$ 92.8 K	USA
Danaher Corporation DHR	55.3	$ 194.79	1.77 %	$ 139 B	USA
Biocept BIOC	112	-	-13.05 %	$ 7.29 M	USA
Heska Corporation HSKA	40.8	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	101	-	-20.0 %	$ 1.06 M	USA
Pacific Biosciences of California PACB	71.8	$ 1.41	3.68 %	$ 423 M	USA
Illumina ILMN	61.3	$ 122.27	2.51 %	$ 19.4 B	USA
Quest Diagnostics Incorporated DGX	44.9	$ 198.48	-0.23 %	$ 22 B	USA
QIAGEN N.V. QGEN	30.8	-	-	$ 10.6 B	Niderland
Agilent Technologies A	63.8	$ 113.6	1.58 %	$ 34.5 B	USA
BioNano Genomics BNGO	83.4	$ 1.12	0.9 %	$ 1.42 M	USA
DarioHealth Corp. DRIO	85.8	$ 9.28	10.24 %	$ 263 M	Israel
NeoGenomics NEO	77.7	$ 8.32	0.97 %	$ 1.07 B	USA
Neogen Corporation NEOG	66.6	$ 9.24	1.43 %	$ 2 B	USA
Lantheus Holdings LNTH	80.5	$ 78.64	0.18 %	$ 5.31 B	USA
Chembio Diagnostics CEMI	66.3	-	0.22 %	$ 16.8 M	USA
Co-Diagnostics CODX	101	$ 4.4	101.83 %	$ 129 M	USA
Medpace Holdings MEDP	50.4	$ 454.41	0.17 %	$ 13.1 B	USA
Motus GI Holdings MOTS	77.2	-	-34.28 %	$ 263 K	Israel
Mettler-Toledo International MTD	66.4	$ 1 214.62	1.33 %	$ 25 B	Schweiz
DermTech DMTK	80.6	-	-11.32 %	$ 2.94 M	USA
National Research Corporation NRC	29.4	$ 17.68	1.61 %	$ 396 M	USA
Twist Bioscience Corporation TWST	44.5	$ 46.69	3.73 %	$ 2.79 B	USA
Invitae Corporation NVTA	242	-	-	$ 21.2 M	USA
Enzo Biochem ENZ	50.3	-	-8.98 %	$ 14.8 K	USA
Natera NTRA	81.5	$ 199.75	1.05 %	$ 19.7 B	USA